Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

450933

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Embryo Experiments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), whether they will place in the Library of the House a full copy of the responses to peer reviewers by the person responsible for the recently approved licence application submitted to the Human Fertilisation and Embryology Authority (HFEA) to perform genome editing in human embryos by means of CRISPR-Cas9; to what extent the HFEA’s Executive followed the recommendations raised by both of their peer reviewers; and on how many occasions the HFEA’s Executive have made decisions against the recommendations of all appointed peer reviewers.
tabling member printed	Lord Alton of Liverpool
uin	HL5959
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) publishes on its website the inspection report relating to a licence renewal application and the minutes of the Licence Committee’s decision. It does not publish other information associated with a licence application.</p><p> </p><p>The Human Fertilisation and Embryology Act 1990 (as amended) permits the genetic modification of embryos in research, subject to an HFEA licence. As the regulator, the HFEA’s responsibility is to apply the test in the legislation, namely that the research is necessary or desirable for any of the purposes specified in the Act and that the use of embryos is necessary. The Licence Committee has added a condition to the licence that no research using genome editing may take place until it has received approval from an NHS Research Ethics Committee.</p> answering member printed Lord Prior of Brampton grouped question UIN HL5649 HL5773 HL5960 question first answered 11/02/2016 17:51:32 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

450934

registered interest
date	08/02/2016
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Human Embryo Experiments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many statutory instruments were laid before Parliament in each session since the 1997 General Election.
tabling member printed	Lord Dobbs
uin	HL5960
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) publishes on its website the inspection report relating to a licence renewal application and the minutes of the Licence Committee’s decision. It does not publish other information associated with a licence application.</p><p> </p><p>The Human Fertilisation and Embryology Act 1990 (as amended) permits the genetic modification of embryos in research, subject to an HFEA licence. As the regulator, the HFEA’s responsibility is to apply the test in the legislation, namely that the research is necessary or desirable for any of the purposes specified in the Act and that the use of embryos is necessary. The Licence Committee has added a condition to the licence that no research using genome editing may take place until it has received approval from an NHS Research Ethics Committee.</p> answering member printed Lord Prior of Brampton grouped question UIN HL5649 HL5773 HL5959 question first answered 11/02/2016 17:51:32 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4192 label Biography information for Lord Dobbs

450942

registered interest
date	08/02/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answers by Lord O’Neill of Gatley on 1 February (HL5090 and HL5091), whether they will now provide the direct link to that information, and why they did not provide that link in those answers.
tabling member printed	Lord Knight of Weymouth
uin	HL5968
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>NHS England is currently finalising the service specification for a forthcoming procurement for genomic laboratory services. The issues around sharing outcome data are under broader consideration as part of the wider genomics programme.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:22:09 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4160 label Biography information for Lord Knight of Weymouth

450943

registered interest
date	08/02/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they have an agreement or understanding with the IRA that there will be no attempts to stop or bring to court its members on charges relating to tax fraud or tax terrorism in South Armagh.
tabling member printed	Lord Laird
uin	HL5969
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Genomics England is familiar with the Broad Institute’s database and it is one of a number of data sources that will be included in their clinical interpretation process.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:20:46 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2479 label Biography information for Lord Laird

450944

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the average waiting time is for a result to be given of a DEXA bone density scan in each NHS region in England; and what assessment they have made of the average waiting time for such results in (1) Scotland, and (2) Wales.
tabling member printed	Baroness Quin
uin	HL5970
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Genomics England has set an objective to deliver 8,000 clinical reports by the end of 2016. The precise details of the reports from the pilot and main phases will become clearer once the phenotypic data is collected and linked to the genome data.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:19:44 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin

450945

registered interest
date	08/02/2016
answering body	Department for Communities and Local Government
answering dept id	7
answering dept short name	Communities and Local Government
answering dept sort name	Communities and Local Government
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are planning to take to ensure that council tax billing authorities pass on to parish and town councils the council tax support funding providing for those councils by the Department for Communities and Local Government.
tabling member printed	Baroness Scott of Needham Market
uin	HL5971
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The patients with clinically actionable reports from the pilot phase are from rare diseases where improved knowledge of the causal mutation improves the management of the patient, their family members and possible future reproductive decisions. The patients diagnosed by whole genome sequencing had not been diagnosed using existing National Health Service panel tests. We are still evaluating the data from the 100,000 Genomes project to identify options for panel testing or other clinical sequencing strategies.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:21:35 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2542 label Biography information for Baroness Scott of Needham Market

451113

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Improvement
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how much money is being spent by NHS Improvement on a re-design of that organisation.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5979
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The forecast spend for the design of NHS Improvement is £800,000. This includes the development of a single organisational structure and new operating model to better support the National Health Service to drive improvements.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 15:00:39 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

451119

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Osteoporosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the average waiting time for a result to be given of a DEXA bone density scan in each NHS region in England; and what assessment they have made of the average waiting time for such results in (1) Scotland, and (2) Wales.
tabling member printed	Baroness Quin
uin	HL5985
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Data are not collected on the average waiting time for a result to be given for a dual energy X-ray absorptiometry (DEXA) scan. Data are collected on the average waiting time from referral to test, and these are shown in the following table for the four NHS England commissioning regions for most recent period, which is November 2015. Health is a devolved matter in Scotland and Wales.</p><p> </p><p>Table: average median waiting times in weeks for a DEXA scan from referral by NHS England commissioning region, November 2015</p><p> </p><table><tbody><tr><td><p>Region</p></td><td><p>Number of weeks</p></td></tr><tr><td><p>North of England</p></td><td><p>2.1</p></td></tr><tr><td><p>Midlands and East of England</p></td><td><p>1.7</p></td></tr><tr><td><p>London</p></td><td><p>1.8</p></td></tr><tr><td><p>South of England</p></td><td><p>1.8</p></td></tr><tr><td><p>England</p></td><td><p>1.9</p></td></tr></tbody></table><p> </p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:18:56 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin

450609

registered interest
date	04/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Embryo Experiments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), whether the recently approved application by the Human Fertilisation and Embryology Authority to perform genome editing in human embryos by means of CRISPR-Cas9 will be performed on embryos specifically created for research or only on those considered to be surplus to infertility treatments; whether that research application included any application for the creation of embryos; and if not, why the person responsible requested that reference to surplus embryos should be removed from the research project title.
tabling member printed	Lord Alton of Liverpool
uin	HL5910
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The Human Fertilisation and Embryology Authority has advised that this research project will make use of donated embryos that were originally created for treatment purposes. An application was not made to create embryos for the purposes of this research project.</p><p> </p><p>The removal of ‘surplus’ from the title does not reflect a change in the way embryos will be donated to the research.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 15:07:15 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

450624

registered interest
date	04/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the planned future HPV vaccine programme will also cover elimination of genital warts.
tabling member printed	Baroness Gould of Potternewton
uin	HL5925
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The Department and Public Health England are currently undertaking a procurement exercise to secure vaccine to support the human papillomavirus (HPV) vaccination programme for girls and as this is a competitive tender, it would not be appropriate to pre-judge the outcome of that exercise. The procurement will take account of the costs and benefits of all vaccines offered to establish which provides best value for money for the National Health Service.</p><p> </p><p>The Department is considering the advice from the Joint Committee on Vaccination and Immunisation regarding HPV vaccination for men who have sex with men. Consideration will be given to the procurement of vaccine.</p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 15:09:17 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	3573 label Biography information for Baroness Gould of Potternewton